Loading institutional data...
Loading institutional data...
Held by 184 of 5,944 reporting institutions (91th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $7.02 today, the market must believe free cash flow compounds -5.8%/yr for a decade (off $96M normalized FCF).
The market's -5.8% is more conservative than its 8-yr track record.
2-stage DCF · 0.05B shares · net debt $367M
mean 35.5% · volatility σ 264% · implied rate exceeded in 2/5 yrs
Central path = implied -5.8%/yr growth; shaded band = ±1σ (264%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Ranked against 1085 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| BCAX | $1.24T | — | — | — | — | — | — | -34.4% | -34.4% | — | 143 |
| LLY | $1.03T | 50.2× | — | 15.9× | 44.7% | 83.0% | 31.7% | 77.8% | 29.9% | — | 4,193 |
| AKTX | $894.1B | — | — | — | — | — | — | -61.1% | -61.1% | — | 1 |
| JNJ | $650.5B | 24.5× | — | 6.9× | 6.0% | 67.9% | 28.5% | 32.9% | 20.7% | — | 4,451 |
| ABBV | $467.1B | 111.9× | 33.4× | 7.6× | 8.6% | 70.2% | 6.9% | -129% | 6.6% | 4.2× | 3,895 |
| MRK | $368.2B | 20.2× | — | 5.7× | 1.3% | 74.8% | 28.1% | 34.7% | 17.9% | — | 3,594 |
| UNH | $339.9B | 28.4× | 19.7× | 0.8× | 11.8% | 88.7% | 2.7% | 12.0% | 6.8% | 3.9× | 2,891 |
| AZN | $257.7B | — | — | — | — | — | — | — | — | — | 1,248 |
| TMO | $248.2B | 37.1× | 31.9× | 5.6× | 3.9% | — | 15.0% | 12.6% | 7.0% | 4.9× | 2,481 |
| AMGN | $204.6B | 26.7× | 17.6× | 5.6× | 10.0% | 67.2% | 21.0% | 89.1% | 12.2% | 3.8× | 3,014 |
| GILD | $187.3B | 22.3× | 20.4× | 6.4× | 2.4% | 78.8% | 28.9% | 37.5% | 17.9% | 2.4× | 2,218 |
| ABT | $178.0B | 27.5× | 19.2× | 4.0× | 5.7% | 56.4% | 14.7% | 12.5% | 10.0% | 1.4× | 2,964 |
| PFE | $157.1B | 20.3× | — | 2.5× | -1.6% | 74.3% | 12.4% | 9.0% | 5.1% | — | 2,838 |
| DHR | $150.2B | 42.1× | 31.0× | 6.1× | 2.9% | 59.1% | 14.7% | 6.9% | 5.1% | 3.4× | 2,083 |
| ISRG | $136.2B | 48.7× | 37.5× | 13.5× | 20.5% | 66.0% | 28.4% | 16.0% | 16.0% | — | 2,190 |
| VRTX | $131.1B | 33.7× | 28.8× | 10.9× | 8.9% | 86.2% | 32.9% | 21.2% | 21.2% | — | 1,609 |
| BMY | $127.8B | 18.2× | — | 2.6× | -0.2% | 71.1% | 14.6% | 38.2% | 11.1% | — | 2,431 |
| MDT | $118.8B | 24.9× | 12.6× | 3.3× | 8.4% | 65.0% | 13.2% | 9.7% | 9.4% | 0.2× | 2,114 |
| CVS | $114.7B | 64.9× | 11.5× | 0.3× | 7.8% | 45.0% | 0.4% | 2.4% | 2.4% | 0.0× | 1,795 |
| SYK | $107.1B | 33.4× | 18.4× | 4.3× | 11.2% | 64.0% | 12.9% | 14.5% | 8.5% | 2.5× | 2,196 |
| MCK | $102.5B | 22.9× | 16.2× | 0.3× | 12.4% | 3.6% | 1.2% | -219% | 109% | 1.0× | 1,946 |
| HCA | $96.4B | 15.1× | — | 1.3× | 7.1% | — | 9.0% | -113% | 16.8% | — | 1,346 |
| ELV | $91.4B | 16.4× | 15.5× | 0.5× | 12.5% | 89.4% | 2.8% | 12.9% | 7.6% | 4.2× | 1,397 |
| REGN | $82.6B | 19.0× | 19.8× | 5.8× | 1.0% | — | 31.4% | 14.4% | 13.6% | 0.5× | 1,336 |
| CI | $72.7B | 12.4× | 5.5× | 0.3× | 11.2% | 21.8% | 2.2% | 14.3% | 14.1% | 0.0× | 1,583 |
| EBS | $366M | 7.5× | 3.7× | 0.5× | -28.8% | 56.1% | 7.1% | 10.1% | 4.8% | 2.9× | 184 |
Peers = companies sharing EBS's sector (Healthcare) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $742.9M 100.0% | $1.04B 100.0% | $1.05B 100.0% | $1.12B 100.0% | $1.77B 100.0% | $1.58B 100.0% | $1.11B 100.0% | $782.4M 100.0% | $560.9M 100.0% | $488.8M 100.0% |
| Cost of Revenue | $326.2M 43.9% | $681.3M 65.3% | $705.4M 67.2% | $693.1M 62.0% | $748.1M 42.2% | $537.0M 34.0% | $433.5M 39.2% | $322.3M 41.2% | $187.7M 33.5% | $126.3M 25.8% |
| Cost of Products | — | — | — | — | — | — | — | — | $195.7M 34.9% | $131.3M 26.9% |
| Gross Profit | — | — | $317.6M 30.3% | $383.0M 34.3% | $891.3M 50.3% | $925.2M 58.7% | — | — | — | — |
| Research & Development | $53.2M 7.2% | $70.7M 6.8% | $111.4M 10.6% | $188.3M 16.9% | $235.2M 13.3% | $237.9M 15.1% | $226.2M 20.5% | $142.8M 18.3% | $97.4M 17.4% | $106.9M 21.9% |
| Selling, General & Admin | $186.1M 25.1% | $308.0M 29.5% | $368.4M 35.1% | $339.5M 30.4% | $348.7M 19.7% | $304.1M 19.3% | $273.5M 24.7% | $202.5M 25.9% | $142.9M 25.5% | $143.1M 29.3% |
| Total Operating Expenses | — | — | — | — | — | — | $991.9M 89.7% | $692.6M 88.5% | $436.6M 77.8% | $383.3M 78.4% |
| Operating Income | $100.1M 13.5% | -$108.7M -10.4% | -$726.4M -69.2% | -$170.0M -15.2% | $341.4M 19.2% | $438.5M 27.8% | $114.1M 10.3% | $89.8M 11.5% | $124.3M 22.2% | $105.5M 21.6% |
| Interest Expense | $59.3M 8.0% | $71.0M 6.8% | $87.9M 8.4% | $37.3M 3.3% | $34.5M 1.9% | $31.3M 2.0% | $38.4M 3.5% | $9.9M 1.3% | $6.6M 1.2% | $7.6M 1.6% |
| Interest & Investment Income | — | — | — | — | — | — | — | — | $1.8M 0.3% | $1.1M 0.2% |
| Other Income (Expense), net | -$17.3M -2.3% | -$34.2M -3.3% | -$4.8M -0.5% | -$49.0M -4.4% | -$38.2M -2.2% | -$26.6M -1.7% | -$36.7M -3.3% | -$8.3M -1.1% | -$5.7M -1.0% | -$6.3M -1.3% |
| Pretax Income | $82.8M 11.1% | -$142.9M -13.7% | -$731.2M -69.7% | -$219.0M -19.6% | $303.2M 17.1% | $411.9M 26.1% | $77.4M 7.0% | $81.5M 10.4% | $118.6M 21.1% | $99.2M 20.3% |
| Income Tax Expense | $30.2M 4.1% | $47.7M 4.6% | $29.3M 2.8% | -$7.4M -0.7% | $83.7M 4.7% | $106.1M 6.7% | $22.9M 2.1% | $18.8M 2.4% | $36.0M 6.4% | $36.7M 7.5% |
| Net Income | $52.6M 7.1% | -$190.6M -18.3% | -$760.5M -72.5% | -$211.6M -18.9% | $219.5M 12.4% | $305.8M 19.4% | $54.5M 4.9% | $62.7M 8.0% | $82.6M 14.7% | $51.8M 10.6% |
| Per Share | ||||||||||
| EPS (Basic) | $0.98 | $-3.60 | $-14.85 | $-4.22 | $4.10 | $5.80 | $1.06 | $1.25 | $1.98 | $1.29 |
| EPS (Diluted) | $0.93 | $-3.60 | $-14.85 | $-4.22 | $4.06 | $5.68 | $1.04 | $1.22 | $1.71 | $1.13 |
| Weighted Avg Shares (Basic) | 53.5M | 53.0M | 51.2M | 50.1M | 53.5M | 52.7M | 51.5M | 50.1M | 41.8M | 40.2M |
| Weighted Avg Shares (Diluted) | 56.7M | 53.0M | 51.2M | 50.1M | 54.1M | 53.8M | 52.4M | 51.4M | 50.3M | 49.3M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Earnings are backed by cash (FCF ≥ net income) — high quality. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage falling year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $25M buybacks = $25M returned on $157M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A reinvestment story — most cash went back into growth rather than to shareholders.
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 5%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $205M covers the $0 due within a year 205400000.0× over. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest. Effective rate ~10.4% on $572M of debt.
Cash vs short-term debt unavailable.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
No material risks flagged.
Where each multiple sits in its own 14-yr range · 5th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 6.7× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 41.2 | 39.2 | 34.0 | 42.2 | 62.0 | 67.2 | 65.3 | 43.9 |
| Gross Profit | — | — | 58.7 | 50.3 | 34.3 | 30.3 | — | — |
| R&D | 18.3 | 20.5 | 15.1 | 13.3 | 16.9 | 10.6 | 6.8 | 7.2 |
| SG&A | 25.9 | 24.7 | 19.3 | 19.7 | 30.4 | 35.1 | 29.5 | 25.1 |
| Operating Income | 11.5 | 10.3 | 27.8 | 19.2 | -15.2 | -69.2 | -10.4 | 13.5 |
| Income Tax | 2.4 | 2.1 | 6.7 | 4.7 | -0.7 | 2.8 | 4.6 | 4.1 |
| Net Income | 8.0 | 4.9 | 19.4 | 12.4 | -18.9 | -72.5 | -18.3 | 7.1 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on EBS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.